Document Detail


Comparative hemodynamic effects of labetalol and hydralazine in the treatment of postoperative hypertension.
MedLine Citation:
PMID:  2627388     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The antihypertensive efficacy and safety of IV labetalol were evaluated and compared with the efficacy and safety of IV hydralazine in the treatment of postoperative hypertension. Twenty patients undergoing major noncardiac surgery were entered into the study. Patients were randomized and treated for postoperative hypertension with either labetalol (n = 10) or hydralazine (n = 10). Labetalol and hydralazine both produced significant reductions in arterial blood pressure (p less than 0.001) within 10 minutes, which lasted at least 2 hours. In addition, labetalol produced a significant reduction in the heart rate and rate-pressure product without creating any adverse effects. In contrast, hydralazine produced significant sinus tachycardia requiring IV propranolol in three patients, two of whom developed transient ST segment depression. These results indicate that labetalol is safe and effective for the control of postoperative hypertension, especially in those patients who are least able to tolerate tachycardia.
Authors:
I Dimich; R Lingham; G Gabrielson; P P Singh; J A Kaplan
Related Documents :
8228208 - Amlodipine and lisinopril in combination for the treatment of essential hypertension: e...
9504938 - The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patient...
2528578 - Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium ant...
947968 - A long-term study of low-dose aerosolized terbutaline sulfate.
3978998 - Effect of propranolol on hepatic blood flow in patients with cirrhosis.
3819798 - Noninvasive continuous blood pressure measurement from the finger: optimal measurement ...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of clinical anesthesia     Volume:  1     ISSN:  0952-8180     ISO Abbreviation:  J Clin Anesth     Publication Date:  1989  
Date Detail:
Created Date:  1990-04-26     Completed Date:  1990-04-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8812166     Medline TA:  J Clin Anesth     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  201-6     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology, Mount Sinai School of Medicine, (CUNY), New York 10029-6574.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Female
Hemodynamics
Humans
Hydralazine / administration & dosage,  therapeutic use*
Hypertension / drug therapy*,  physiopathology
Labetalol / administration & dosage,  therapeutic use*
Male
Middle Aged
Postoperative Complications / drug therapy*
Tachycardia / drug therapy*,  physiopathology
Chemical
Reg. No./Substance:
36894-69-6/Labetalol; 86-54-4/Hydralazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Attenuation of the hemodynamic responses to endotracheal intubation with preinduction intravenous la...
Next Document:  Endobronchial rupture from endotracheal reintubation with an endotracheal tube guide.